5A71.0

ICD-11 MMS 2026-01

46,XX disorders of sex development induced by androgens of fetal origin

Description

This refers to 46,XX disorders of sex development induced by any natural or synthetic compound, usually a steroid hormone, that stimulates or controls the development and maintenance of male characteristics in vertebrates by binding to androgen receptors, of fetal origin.

Exclusions from above levels

  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

  • 5A71.00 – Glucocorticoid resistance
  • 5A71.01 – Congenital adrenal hyperplasia
  • 5A71.0Y – Other specified 46,XX disorders of sex development induced by androgens of fetal origin
  • 5A71.0Z – 46,XX disorders of sex development induced by androgens of fetal origin, unspecified

Sibling codes

  • 5A71.1 – 46,XX disorders of sex development induced by androgens of maternal origin
  • 5A71.Y – Other specified adrenogenital disorders
  • 5A71.Z – Adrenogenital disorders, unspecified

Foundation entity

46,XX disorders of sex development induced by androgens of fetal origin – http://id.who.int/icd/entity/1842263206

Part of: 5A71: Adrenogenital disorders › 05: Endocrine, nutritional or metabolic diseases